Kronberger L, Semmelrock H J, Schaur R J, Schauenstein E, Schreibmayer W, Fink E
J Cancer Res Clin Oncol. 1980;97(3):295-9. doi: 10.1007/BF00405781.
A 4-year survey is presented on the alpha-ketoglutarate (KG) values in whole blood of 200 patients with malignant neoplasms mainly of the gastrointestinal tract and the female breast. A group of patients with benign surgical diseases served as control. KG showed an association with the extent of the primary tumor classified according to the TNM-scheme. The percentages of single values above the 2s-range of the control were as follows: T2: 18%,T3: 41%, and T4: 64%. The mean value of KG had highly significantly increased already in stage T2 as compared to the control group. Rats bearing the Yoshida sarcoma showed a significant correlation between the tumor size and the daily excretion of KG into urine during the early stage of tumor growth. The results suggested that KG cannot be regarded as an early tumor marker in humans, but may be of some value as an aid for the differential diagnosis in advanced tumor stages.
本文呈现了一项为期4年的调查结果,该调查针对200例主要患有胃肠道和女性乳腺癌恶性肿瘤患者的全血中α-酮戊二酸(KG)值展开。一组患有良性外科疾病的患者作为对照。KG与根据TNM分期系统分类的原发性肿瘤范围相关。高于对照组2s范围的单个值百分比分别为:T2期:18%,T3期:41%,T4期:64%。与对照组相比,在T2期KG的平均值就已显著升高。携带吉田肉瘤的大鼠在肿瘤生长早期,肿瘤大小与每日尿中KG排泄量之间存在显著相关性。结果表明,KG不能被视为人类的早期肿瘤标志物,但在晚期肿瘤阶段的鉴别诊断中可能具有一定价值。